TY - JOUR
T1 - Genome-wide association study of coronary artery disease in the Japanese
AU - Takeuchi, Fumihiko
AU - Yokota, Mitsuhiro
AU - Yamamoto, Ken
AU - Nakashima, Eitaro
AU - Katsuya, Tomohiro
AU - Asano, Hiroyuki
AU - Isono, Masato
AU - Nabika, Toru
AU - Sugiyama, Takao
AU - Fujioka, Akihiro
AU - Awata, Nobuhisa
AU - Ohnaka, Keizo
AU - Nakatochi, Masahiro
AU - Kitajima, Hidetoshi
AU - Rakugi, Hiromi
AU - Nakamura, Jiro
AU - Ohkubo, Takayoshi
AU - Imai, Yutaka
AU - Shimamoto, Kazuaki
AU - Yamori, Yukio
AU - Yamaguchi, Shuhei
AU - Kobayashi, Shotai
AU - Takayanagi, Ryoichi
AU - Ogihara, Toshio
AU - Kato, Norihiro
N1 - Funding Information:
We thank all the people who have continuously supported the Hospital-based Cohort Study at the National Center for Global Health and Medicine, the Amagasaki Study and the Kyushu University Fukuoka Cohort Study, and the KING Study. We also thank Drs Suminori Kono, Ken Sugimoto, Kei Kamide, and Chikanori Makibayashi, and the many physicians of the participating hospitals and medical institutions for their assistance in collecting the DNA samples and accompanying clinical information. This work was supported by grants for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency; the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); and KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas ‘Applied Genomics’ from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PY - 2012/3
Y1 - 2012/3
N2 - A new understanding of the genetic basis of coronary artery disease (CAD) has recently emerged from genome-wide association (GWA) studies of common single-nucleotide polymorphisms (SNPs), thus far performed mostly in European-descent populations. To identify novel susceptibility gene variants for CAD and confirm those previously identified mostly in populations of European descent, a multistage GWA study was performed in the Japanese. In the discovery phase, we first genotyped 806 cases and 1337 controls with 451 382 SNP markers and subsequently assessed 34 selected SNPs with direct genotyping (541 additional cases) and in silico comparison (964 healthy controls). In the replication phase, involving 3052 cases and 6335 controls, 12 SNPs were tested; CAD association was replicated and/or verified for 4 (of 12) SNPs from 3 loci: near BRAP and ALDH2 on 12q24 (P1.6 × 10 -34), HLA-DQB1 on 6p21 (P4.7 × 10 -7), and CDKN2A/B on 9p21 (P6.1 × 10 -16). On 12q24, we identified the strongest association signal with the strength of association substantially pronounced for a subgroup of myocardial infarction cases (P1.4 × 10 -40). On 6p21, an HLA allele, DQB1 0604, could show one of the most prominent association signals in an ∼8-Mb interval that encompasses the LTA gene, where an association with myocardial infarction had been reported in another Japanese study. CAD association was also identified at CDKN2A/B, as previously reported in different populations of European descent and Asians. Thus, three loci confirmed in the Japanese GWA study highlight the likely presence of risk alleles with two types of genetic effects-population specific and common-on susceptibility to CAD.
AB - A new understanding of the genetic basis of coronary artery disease (CAD) has recently emerged from genome-wide association (GWA) studies of common single-nucleotide polymorphisms (SNPs), thus far performed mostly in European-descent populations. To identify novel susceptibility gene variants for CAD and confirm those previously identified mostly in populations of European descent, a multistage GWA study was performed in the Japanese. In the discovery phase, we first genotyped 806 cases and 1337 controls with 451 382 SNP markers and subsequently assessed 34 selected SNPs with direct genotyping (541 additional cases) and in silico comparison (964 healthy controls). In the replication phase, involving 3052 cases and 6335 controls, 12 SNPs were tested; CAD association was replicated and/or verified for 4 (of 12) SNPs from 3 loci: near BRAP and ALDH2 on 12q24 (P1.6 × 10 -34), HLA-DQB1 on 6p21 (P4.7 × 10 -7), and CDKN2A/B on 9p21 (P6.1 × 10 -16). On 12q24, we identified the strongest association signal with the strength of association substantially pronounced for a subgroup of myocardial infarction cases (P1.4 × 10 -40). On 6p21, an HLA allele, DQB1 0604, could show one of the most prominent association signals in an ∼8-Mb interval that encompasses the LTA gene, where an association with myocardial infarction had been reported in another Japanese study. CAD association was also identified at CDKN2A/B, as previously reported in different populations of European descent and Asians. Thus, three loci confirmed in the Japanese GWA study highlight the likely presence of risk alleles with two types of genetic effects-population specific and common-on susceptibility to CAD.
UR - http://www.scopus.com/inward/record.url?scp=84857192818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857192818&partnerID=8YFLogxK
U2 - 10.1038/ejhg.2011.184
DO - 10.1038/ejhg.2011.184
M3 - Article
C2 - 21971053
AN - SCOPUS:84857192818
SN - 1018-4813
VL - 20
SP - 333
EP - 340
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 3
ER -